Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases.
Buture A, Tomkins EM, Shukralla A, Troy E, Conaty K, Macken E, Lonergan R, Melling J, Long N, Birrane K, Shaikh E, Goadsby PJ, Ruttledge MH. Buture A, et al. Among authors: shaikh e. Cephalalgia. 2023 Jun;43(6):3331024231182126. doi: 10.1177/03331024231182126. Cephalalgia. 2023. PMID: 37317535 Free article.
Medium-term real-world data for erenumab in 177 treatment resistant or difficult to treat chronic migraine patients: persistence and patient reported outcome measures after 17-30 months.
Troy E, Shrukalla AA, Buture A, Conaty K, Macken E, Lonergan R, Melling J, Long N, Shaikh E, Birrane K, Tomkins EM, Goadsby PJ, Ruttledge MH. Troy E, et al. Among authors: shaikh e. J Headache Pain. 2023 Jan 16;24(1):5. doi: 10.1186/s10194-022-01536-3. J Headache Pain. 2023. PMID: 36647006 Free PMC article.
Phase 2 Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1 Pretreated Metastatic Non-Small Cell Lung Cancer and Metastatic Cutaneous Melanoma.
Lee S, Hamid O, Jotte R, Zakharia Y, Medina T, Gillespie-Twardy A, Mehmi I, Chandra S, Watson G, Ward P, Chaney M, Lu H, Berndt J, O'Connor BP, Rathi K, Shaikh E, Cowey CL. Lee S, et al. Among authors: shaikh e. Clin Cancer Res. 2024 Dec 30. doi: 10.1158/1078-0432.CCR-24-1478. Online ahead of print. Clin Cancer Res. 2024. PMID: 39786430
Verification of 2021 IDF-DAR risk assessment tool for fasting Ramadan in patients with diabetes attending primary health care in The Kingdom of Bahrain: The DAR-BAH study.
Shamsi N, Naser J, Humaidan H, Al-Saweer A, Jaafar M, Abbas F, Al-Doseri S, Shabeeb N, Al-Shaikh E, Al-Dairi A, Mandoos K. Shamsi N, et al. Among authors: al shaikh e. Diabetes Res Clin Pract. 2024 May;211:111661. doi: 10.1016/j.diabres.2024.111661. Epub 2024 Apr 10. Diabetes Res Clin Pract. 2024. PMID: 38604445 Free article. Clinical Trial.
Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD.
Balogun O, Wang JY, Shaikh ES, Liu K, Stoyanova S, Memel ZN, Schultz H, Mun L, Bertman J, Rogen CA, Ibrahim MK, Berschback M, Uche-Anya E, Wilechansky R, Simon TG, Corey KE. Balogun O, et al. Among authors: shaikh es. Hepatol Commun. 2023 Oct 27;7(11):e0300. doi: 10.1097/HC9.0000000000000300. eCollection 2023 Nov 1. Hepatol Commun. 2023. PMID: 37889558 Free PMC article.
Recruitment characteristics and non-adherence associated factors of fibromyalgia patients in a randomized clinical trial: A retrospective survival analysis.
Cardenas-Rojas A, Castelo-Branco L, Pacheco-Barrios K, Shaikh ES, Uygur-Kucukseymen E, Giannoni-Luza S, Vasconcelos Felippe L, Gonzalez-Mego P, Luna-Cuadros MA, Gianlorenco ACL, Teixeira PEP, Caumo W, Fregni F. Cardenas-Rojas A, et al. Among authors: shaikh es. Contemp Clin Trials Commun. 2021 Nov 17;24:100860. doi: 10.1016/j.conctc.2021.100860. eCollection 2021 Dec. Contemp Clin Trials Commun. 2021. PMID: 34849424 Free PMC article.
Is Surfer's myelopathy an acute hyperextension-induced myelopathy? A systematic synthesis of case studies and proposed diagnostic criteria.
Alva-Díaz C, Rodriguez-López E, López-Saavedra A, Metcalf T, Morán-Mariños C, Navarro-Flores A, Velásquez-Rimachi V, Aguirre-Quispe W, Shaikh ES, Mori N, Romero-Sanchez R, Pacheco-Barrios K. Alva-Díaz C, et al. Among authors: shaikh es. J Neurol. 2022 Apr;269(4):1776-1785. doi: 10.1007/s00415-021-10775-4. Epub 2021 Sep 3. J Neurol. 2022. PMID: 34477933 Review.
Barriers and facilitators for clinical trial participation of underrepresented and non-underrepresented fibromyalgia patients: A cross-sectional internet survey.
Cardenas-Rojas A, Pacheco-Barrios K, Castelo-Branco L, Giannoni-Luza S, Balbuena-Pareja A, Luna-Cuadros MA, Vasconcelos Felippe L, Uygur-Kucukseymen E, Gonzalez-Mego P, Gunduz ME, Shaikh ES, Gianlorenco ACL, Fregni F. Cardenas-Rojas A, et al. Among authors: shaikh es. Heliyon. 2021 Jul 5;7(7):e07475. doi: 10.1016/j.heliyon.2021.e07475. eCollection 2021 Jul. Heliyon. 2021. PMID: 34286136 Free PMC article.
19 results